Medinova Diagnostic Services Inc Stock Price Today (NSE: MEDINOV)
Medinova Diagnostic Services Inc
Fundamental Score
Medinova Diagnostic Services Inc Share Price Live NSE/BSE & Institutional Fundamental Analysis
Medinova Diagnostic Services Inc share price today is ₹43.45, up +0.00% on NSE/BSE as of 2 January 2026. Medinova Diagnostic Services Inc (MEDINOV) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹43.37 (Cr). The 52-week high for MEDINOV share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 20.17x, MEDINOV is currently trading below its industry average P/E of 39.28x.
Medinova Diagnostic Services Inc Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Medinova Diagnostic Services Inc Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Medinova Diagnostic Services Inc Share Price: A Financial Stability Analysis
The healthcare service provider industry faces increasing pressure to deliver accurate and timely results while managing operational costs effectively. This analysis delves into the financial stability of Medinova Diagnostic Services Inc, specifically focusing on the Medinova Diagnostic Services Inc share price and key performance indicators. Currently, the share price is ₹43.45, with a Price-to-Earnings (PE) ratio of 20.17. This report is part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra.
A critical area of focus is Medinova's Return on Capital Employed (ROCE), which stands at an impressive 108.87%. This exceptionally high ROCE suggests that Medinova Diagnostic Services Inc. is highly efficient in generating profits from its invested capital. In practical terms, it indicates a potential widening of the company's economic moat, as competitors may struggle to match this level of profitability. However, sustaining such a high ROCE over the long term necessitates consistent operational excellence and strategic capital allocation. A high ROCE alone doesn't guarantee success and needs continuous monitoring.
Benchmarking Medinova against its sector peers provides valuable insights. For example, comparing Medinova Diagnostic Services Inc with peers such as
Suraksha Diagnostic Ltd regarding management quality, as perceived through operational efficiency and strategic decision-making, could reveal areas of relative strength or weakness. Factors like employee satisfaction, investor communication and stakeholder relations are all taken into consideration when benchmarking management quality.While the PE ratio of 20.17 offers a snapshot of investor sentiment regarding future earnings potential, it’s essential to consider this in conjunction with other factors. A detailed examination of Medinova's financial statements, including revenue growth, debt levels, and cash flow generation, will provide a more holistic view of its financial stability. The relatively high ROCE warrants further scrutiny to understand the drivers behind it, whether it stems from pricing power, cost advantages, or a combination of both. These aspects are crucial to assess the long-term sustainability of Medinova Diagnostic Services Inc's current financial performance.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Medinova Diagnostic Services Inc Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MEDINOV across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Excellent ROCE Performance (108.87%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (27.35%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 20.17 vs Industry: 39.28)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Excellent EPS Growth (56.49% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (56.49% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (7.35x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (62.14%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Medinova Diagnostic Services Inc Financial Statements
Comprehensive financial data for Medinova Diagnostic Services Inc including income statement, balance sheet and cash flow
About MEDINOV (Medinova Diagnostic Services Inc)
Medinova Diagnostic Services Inc (MEDINOV) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Healthcare Service Provider sector with a current market capitalisation of ₹43.37 (Cr). Investors tracking MEDINOV share price can monitor key metrics including P/E ratio, promoter holding of 62.14%, and quarterly earnings growth.
Company Details
Key Leadership
MEDINOV Share Price: Frequently Asked Questions
What is the current share price of Medinova Diagnostic Services Inc (MEDINOV)?
As of 02 Jan 2026, 06:00 pm IST, Medinova Diagnostic Services Inc share price is ₹43.45. The MEDINOV stock has a market capitalisation of ₹43.37 (Cr) on NSE/BSE.
Is MEDINOV share price Overvalued or Undervalued?
MEDINOV share price is currently trading at a P/E ratio of 20.17x, compared to the industry average of 39.28x. Based on this relative valuation, the Medinova Diagnostic Services Inc stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of MEDINOV share price?
The 52-week high of MEDINOV share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Medinova Diagnostic Services Inc share price?
Key factors influencing MEDINOV share price include quarterly earnings growth (Sales Growth: -2.34%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Medinova Diagnostic Services Inc a good stock for long-term investment?
Medinova Diagnostic Services Inc shows a 5-year Profit Growth of 56.49% and an ROE of N/A%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of N/A before investing in MEDINOV shares.
How does Medinova Diagnostic Services Inc compare with its industry peers?
Medinova Diagnostic Services Inc competes with major peers in the Healthcare Service Provider. Investors should compare MEDINOV share price P/E of 20.17x and ROE of N/A% against the industry averages to determine competitive standing.
What is the P/E ratio of MEDINOV and what does it mean?
MEDINOV share price has a P/E ratio of 20.17x compared to the industry average of 39.28x. Investors pay ₹20 for every ₹1 of annual earnings.
How is MEDINOV performing according to Bull Run's analysis?
MEDINOV has a Bull Run fundamental score of 49/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does MEDINOV belong to?
MEDINOV operates in the Healthcare Service Provider industry. This classification helps understand the competitive landscape and sector-specific trends affecting Medinova Diagnostic Services Inc share price.
What is Return on Equity (ROE) and why is it important for MEDINOV?
MEDINOV has an ROE of N/A%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Medinova Diagnostic Services Inc generates profits from shareholders capital.
How is MEDINOV debt-to-equity ratio and what does it indicate?
MEDINOV has a debt-to-equity ratio of N/A, which indicates conservative financing with low financial risk.
What is MEDINOV dividend yield and is it a good dividend stock?
MEDINOV offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Medinova Diagnostic Services Inc shares.
How has MEDINOV share price grown over the past 5 years?
MEDINOV has achieved 5-year growth rates of: Sales Growth 5.66%, Profit Growth 56.49%, and EPS Growth 56.49%.
What is the promoter holding in MEDINOV and why does it matter?
Promoters hold 62.14% of MEDINOV shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Medinova Diagnostic Services Inc.
What is MEDINOV market capitalisation category?
MEDINOV has a market capitalisation of ₹43 crores, placing it in the Small-cap category.
How volatile is MEDINOV stock?
MEDINOV has a beta of N/A. A beta > 1 suggests the Medinova Diagnostic Services Inc stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is MEDINOV operating profit margin trend?
MEDINOV has a 5-year average Operating Profit Margin (OPM) of 27.35%, indicating the company's operational efficiency.
How is MEDINOV quarterly performance?
Recent quarterly performance shows Medinova Diagnostic Services Inc YoY Sales Growth of -2.34% and YoY Profit Growth of 2.00%.
What is the institutional holding pattern in MEDINOV?
MEDINOV has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Medinova Diagnostic Services Inc stock.